20918 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Mitochondrial-targeted cationic nanoparticles comprising CaMKII inhibitors and uses thereof for treating and preventing diseases and disorders associated with CaMKII activity
#3302Methods For Affecting Body Composition
#3303Methods of treating virally-infected living cells with histones
#3304Methods and compositions relating to mesenchymal stem cell exosomes
#3305ZSCAN4 as a marker for pancreatic stem cells and progenitor cells and use thereof
#3306Wild-type apolipoprotein L-I for use in the prevention of kidney diseases
#3307OSTEOBLAST-EXPRESSED LIPOCALIN 2 REGULATES GLUCOSE METABOLISM
#3308Methods for Improving Fracture Healing and Bone Formation
#3309Pharmaceutical composition for treating hyperproliferative diseases
#3310Oxidant resistant apolipoprotein A-1 and mimetic peptides
#3311Use of AGR3 for treating cancer
#3312Methods for Treating and Preventing Cardiac Dysfunction in Septic Shock
#3313Method of treating a disease or condition characterised by aberrant epithelial cell proliferation
#3314Compositions and methods for modulating BRD4 bioactivity
#3315ANKYRIN G AND MODULATORS THEREOF FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
#3316Therapeutic and diagnostic methods involving biglycan and utrophin
#3317Modulation of LRCH4 activity and therapeutic application thereof
#3318Composition comprising expression or activity inhibitors of Ninjurin1 for the prevention and treatment of inflammatory disease
#3319THERAPEUTIC AND PROPHYLACTIC METHODS, USES AND COMPOSITIONS COMPRISING ANEXIN A5
#3320Biological activity of placental protein 13
#3321Methods of screening compounds for the fibril formation of Aβ peptides based on a decreased trimer/monomer ratio of a chaperone protein
#3322Methods and compositions for modulating PD1
#3323Methods and compositions for treatment of disease or injury of the nervous system
#3324COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIAC ISCHEMIC INJURY
#3325METHOD FOR INDUCING SUSTAINED IMMUNE RESPONSE
#3326ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES FOR TREATING AGE-RELATED MACULAR DEGENERATION
#3327Cancer therapies and diagnostics
#3328Method for the production of protein complexes and vaccine compositions comprising the same
#3329Nucleic acid encoding superoxide dismutase variants and methods of use thereof
#3330Viral vectors for the treatment of retinal dystrophy
#3331Methods for treating metabolic syndrome with Cthrc1 polypeptide
#3332LIPOSOMES FOR PROTECTION AGAINST TOXIC COMPOUNDS
#3333Chimeric peptides comprising HER-2 B-cell epitopes and Tcell helper epitopes
#3334Use of CD83 in combination therapies
#3335Methods of treating muscular wasting diseases using NF-KB activation inhibitors
#3336Activity enhancer for anticancer agent
#3337Apolipoprotein AIV as an antidiabetic peptide
#3338Plasma anti-diabetic NUCB2 peptide (pladin) and uses thereof
#3339Compositions and methods for modulating the immune system
#3340POLYAMIDE-AMINE DENDRIMER OR DERIVATIVE THEREOF-MATH1 GENE NANO PARTICLE AND USE THEREOF IN TREATMENT OF HEARING LOSS
#3341Methods for treating burns-related systemic inflammatory response syndrome
#3342ATIP3 AND BIOLOGICALLY ACTIVE FRAGMENTS THEREOF FOR USE IN THE TREATMENT OF CANCER
#3343Method of Use of Activated Functional Proteins to Improve Animal Health
#3344Control and characterization of memory function
#3345COMPOSITIONS AND METHODS FOR TREATING AN ACTIVATED B-CELL DIFFUSE LARGE B-CELL LYMPHOMA
#3346Preparation of a Therapeutic Composition
#3347Dry powder inhaler and system for drug delivery
#3348Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
#3349Chimeric fibronectin matrix mimetics and uses therof
#3350Coronin 1 modulators for the treatment of autoimmune and lymphoproliferative disorders and mycobacterial infections
#3351Antimicrobial fusion compounds and uses thereof
#3352MATERIAL COMBINATION FOR TREATING INFLAMMATORY OR INFECTIOUS DISEASES
#3353HOX COMPOSITIONS AND METHODS
#3354Annexin II compositions
#3355Materials presenting notch signaling molecules to control cell behavior
#3356BIOMARKERS FOR SEIZURES
#3357Process for producing a composition containing active follistatin
#3358Treatment of angiogenesis disorders
#3359Medical treatment composition comprising mammalian dental pulp stem cells
#3360Serum Amyloid A (SAA) Overrides Regulatory T Cells (TREG) Anergy
#3361Therapeutic method for treating congestive heart failure
#3362Diagnostic and therapeutic uses of moesin fragments
#3363Gelsolin stimulation of blood samples using gold particles
#3364Methods for treating disorders that involve immunoglobulin A
#3365Inhibition of choroidal neovascularization
#3366EXTENDED RECOMBINANT POLYPEPTIDE-MODIFIED C-PEPTIDE
#3367Anti-trypanosomal peptides and uses thereof
#3368Method for inducing lymphoid tissue and modulating intestinal homeostasis
#3369Histatin for Corneal Wound Healing and Ocular Surface Disease
#3370Histatin for Corneal Wound Healing and Ocular Surface Disease
#3371Site-directed PEG-modified exendin-4 analogs and uses thereof
#3372METHODS AND COMPOSITIONS FOR TREATMENT OF MULTIDRUG-RESISTANT BACTERIAL AND FUNGAL INFECTIONS
#3373Methods for increasing plasmin activity and promoting plaque regression in the treatment of atherosclerosis
#3374Medical treatment composition comprising mammalian dental pulp stem cells
#3375Compositions comprising perivascular stem cells and nell-1 protein
#3376Manufacture of factor H (FH) and FH-derivatives from plasma
#3377Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
#3378Methods for modulating immune responses
#3379INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES
#3380Peptides and Peptide Mimetics to Treat Pathologies Associated With Eye Disease
#3381Dry powder inhaler and system for drug delivery
#3382Fused ring compound for use as mineralocorticoid receptor antagonist
#3383THERAPEUTIC AGENT FOR PULMONARY SMALL CELL CARCINOMA
#3384Inhibitors of apoptosis and uses thereof
#3385Use of peptides for promoting wound healing
#3386Use of peptides for promoting wound healing
#3387Methods for treating steatotic disease
#3388Flowable implant with crosslinkable surface membrane
#3389Treatment for dupuytren's disease
#3390Methods of treating retinitis pigmentosa using nucleic acids encoding RDCVF1 or RDCVF2
#3391Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
#3392Methods and compositions for modulating Toso activity
#3393Amniotic membrane preparations and purified compositions and anti-inflammation methods
#3394Compositions comprising β-arrestin 1 and methods of use thereof for therapeutic modulation of aldosterone levels in heart disease
#3395Obesity-related genes and their proteins and uses thereof
#3396TREFOIL FACTORS (TFF) FOR THE TREATMENT OF CHRONIC PULMONARY DISEASES
#3397Screening methods for identifying Sp35 antagonists
#3398Therapeutic Compositions For Treatment Of Inflammation Of Ocular And Adnexal Tissues
#3399Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated N-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
#3400Formulations and methods of use for alpha connexin C-terminal (ACT) peptides
#3401Treatment of penetrative injury to the brain
#3402Therapeutic applications of SMAD7
#3403Methods for treatment of nephrotic syndrome and related conditions
#3404Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein A-I and a mutant thereof
#3405Methods for Modulating Inflammatory Responses
#3406Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
#3407Compositions comprising signal peptide-containing proteins
#3408METHODS FOR PREDICTING AND TREATING INFECTION-INDUCED ILLNESSES AND PREDICTING THE SEVERITY OF INFECTION-INDUCED ILLNESSES
#3409MICROPARTICLES COMPRISING A SMALL HEAT-SHOCK PROTEIN
#3410Use of decorin for increasing muscle mass
#3411Novel Peptide Involved in Energy Homeostasis
#3412Protein involved in ovarian cancer
#3413Pharmaceutical composition for treating bone diseases which comprises protein comprising Frizzled1, Frizzled2 or Frizzled7 extracellular cysteine-rich domain
#3414USE OF GELSOLIN TO TREAT MULTIPLE SCLEROSIS AND TO DIAGNOSE NEUROLOGIC DISEASES
#3415TEX14 PEPTIDES AS NOVEL ANTITUMOR AGENTS
#3416NOVEL USE OF ERYTHROID DIFFERENTIATION REGULATOR 1 AS AN AGENT FOR TREATING CANCER
#3417Methods of Treating Glucose Metabolism Disorders and Promoting Weight Loss
#3418CCN3 and CCN3 peptides and analogs thereof for therapeutic uses
#3419Methods for generating cardiomyocytes
#3420USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#3421Method of achieving a thymosin beta 4 concentration in a human patient
#3422Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
#3423Prevention and treatment of alzheimer's disease by amyloid beta peptide and sphin-gosine-1-phosphate
#3424Methods for modulating skeletal remodeling and patterning by modulating SHN2 activity, SHN3 activity, or SHN2 and SHN3 activity in combination
#3425Retinoid replacements and opsin agonists and methods for the use thereof
#3426Methods and compositions inhibiting tumor cell proliferation
#3427Polynucleotides encoding recombinant lubricin molecules and uses thereof
#3428SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE (SPARC) AS CHEMOTHERAPEUTIC SENSITIZERS
#3429Compositions and methods useful in enhancement of memory
#3430Methods for cardioprotection and cardioregeneration with dimers of EGF family ligands
#3431Use of glycomacropeptide to improve women's health
#3432Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#3433Purified amniotic membrane compositions and methods of use
#3434Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
#3435Composition of whey growth factor extract for reducing muscle inflammation
#3436Removal of serine proteases by treatment with finely divided silicon dioxide
#3437NOVEL MODULATORS OF TRAIL SIGNALLING
#3438Methods and Pharmaceutical Compositions for the Treatment of Bone Density Related Diseases
#3439Methods of altering bone growth by administration of sost or wise antagonist or agonist
#3440METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY
#3441Reconstituted high density lipoprotein formulation and production method thereof
#3442MODULATION OF SIRP-ALPHA - CD47 INTERACTION FOR INCREASING HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT AND COMPOUNDS THEREFOR
#3443Methods of increasing efficiency of vector penetration of target tissue
#3444Pharmaceutical composition for suppressing angiogenesis, and method for screening active material for suppressing angiogenesis
#3445METHODS FOR INHIBITING TUMOR GROWTH
#3446Inhibiting binding of FGF23 to the binary FGFR-Klotho complex for the treatment of chronic kidney disease and symptoms and/or complications thereof
#3447Methods and compositions for the inhibition of Stat5 in prostate cancer cells
#3448MIA-2 PROTEIN
#3449METHODS FOR MODULATING SLOW MYOSIN
#3450Nano-vehicle derived from tumor tissue, and cancer vaccine using same
#3451Treatment of synucleinopathies
#3452Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and applications thereof
#3453Cancer therapy based on tumor associated antigens derived from cyclin D1
#3454Pharmaceutical composition comprising N-acetyl-L-cysteine or its derivatives for treating anxiety disorder
#3455Selective inhibition of polyglutamine protein expression
#3456Pharmaceutical compositions including a portion of the C-terminus of FGF23
#3457Prevention and Treatment of Ischemia-Reperfusion Injury and Related Conditions
#3458TREATMENT OF ABNORMALITIES OF GLUCOSE METABOLISM WITH AN ANTAGONIST OF INHIBITOR OF DIFFERENTIATION 1
#3459β2-glycoprotein I peptide inhibitors
#3460Decellularized small particle tissue
#3461METHOD OF TREATING OBESITY AND METABOLIC DISORDERS RELATED TO EXCESS ADIPOSE TISSUE BY ADMINISTRATION OF sFRP-- PEPTIDE
#3462Compositions and methods for detecting, diagnosing, and treating cancer
#3463Stable high lipid liquid formula
#3464NGAL AND URINARY TRACT INFECTION
#3465PROTEASE ENZYMES FOR INCREASED PROTEIN DIGESTION RATE AND ABSORPTION AND METHODS OF USING THE SAME
#3466HSP70 fusion protein conjugates and uses thereof
#3467Improving efficacy of cancer therapy
#3468Method for promoting regeneration of pancreatic beta-cells by administering neurturin
#3469Immobilized biologically active entities having a high degree of biological activity
#3470Device and method for the controlled delivery of ophthalmic solutions
#3471Protein therapy for corneal inflammation, epithelial wound healing, and photoreceptor degeneration
#3472Compositions comprising spp24 peptide fragments
#3473Compositions for inhibition of RNA polymerase I and methods of production and use thereof
#3474Administration of transfer factor for improving reproductive health
#3475ATHEROSCLEROSIS INHIBITION VIA MODULATION OF MONOCYTE-MACROPHAGE PHENOTYPE USING APO A-I MILANO GENE TRANSFER
#3476Retractor
#3477Stable MIA/CD-RAP formulation
#3478Methods of Treating Glucose Metabolism Disorders
#3479Protein fusion constructs possessing thrombolytic and anticoagulant properties
#3480Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases
#3481Methods of treating glucose metabolism disorders
#3482Method for inhibiting HIV replication in mammal and human cells
#3483Regional delivery of therapeutic agents for the treatment of vascular diseases
#3484Self-renewal promoter for neural stem cells and method for using same
#3485Integrin receptor antagonists and their methods of use
#3486MODULATION OF CYTOKINE-INDUCED CHRONIC INFLAMMATORY RESPONSES
#3487Modulation of scleraxis using a dominant negative scleraxis mutant with a basic DNA-binding domain deletion
#3488Methods for diagnosing and treating alzheimer's disease (AD) using the molecules that stabilize intracellular calcium (Ca) release
#3489METHODS OF TREATING AND DIAGNOSING ACUTE CHEST SYNDROME
#3490HUMANIN AND HUMANIN-ANALOGUES FOR THE MANAGEMENT OF ATHEROSCLEROSIS
#3491ENCAPSULATED TRANSFER FACTOR COMPOSITIONS AND METHODS OF USE
#3492Method and pharmacological composition for the diagnosis and treatment of male sub-fertility
#3493Use of peptides as transporters intended for the internalization of molecules of interest into target cells
#3494Peptide epitopes of apolipoprotein B
#3495Peptide epitopes of apolipoprotein B
#3496Peptide epitopes of apolipoprotein B
#3497Peptide epitopes of apolipoprotein B
#3498Reducer of immunosuppression by tumor cell and antitumor agent using the same
#3499HIFα hydroxylation assay
#3500Humanin Decreases Liver Fat and Visceral Fat Accumulation
#3501Casein peptide for use in the treatment of uterine infections
#3502METHODS FOR INHIBITING NECROSIS
#3503Modulation of UL24 interactions with protein targets and uses thereof for inhibition of herpesvirus infection
#3504Use of a granulin or a granulin-like compound for the therapy or prophylaxis of chronic pain
#3505METHODS OF INHIBITING TUMOR CELL AGGRESSIVENESS USING THE MICROENVIRONMENT OF HUMAN EMBRYONIC STEM CELLS
#3506Manufacture of factor H (FH) and FH-derivatives from plasma
#3507Method to produce an immunoglobulin preparation with improved yield
#3508Degradation resistant HSP70 formulations and uses thereof
#3509METHODS OF INHIBITING INFLAMMATION AND INFLAMMATORY DISEASES USING Gal-3BP (BTBD17B, LGALS3BP, GALECTIN-3 BINDING PROTEIN, MAC-2 BINDING PROTEIN)
#3510Bone morphogenic protein binding peptide
#3511Compositions and methods for preserving insulin-producing cells and insulin production and treating diabetes
#3512REGULATION OF LUNG TISSUE BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO
#3513Polynucleotide encoding a TRIM-cyp polypeptide, compositions thereof, and methods of using same
#3514Muteins of human lipocalin 2 (LcnC,hNGAL) with affinity for a given target
#3515Removal of serine proteases by treatment with finely divided silicon dioxide
#3516Retinoid replacements and opsin agonists and methods for the use thereof
#3517Compositions and methods for the treatment of asthma and associated disorders
#3518Anti-inflammatory pharmaceutical products
#3519STABILIZED MUTANT OPSIN PROTEINS
#3520Tribonectins
#3521Saposin-A derived peptides and uses thereof
#3522Isolated nucleotide sequences encoding GDF traps
#3523Methods of Treating Glucose Metabolism Disorders
#3524Methods for treating muscular dystrophy
#3525NOTCH inhibition in the treatment and prevention of a metabolic disease or disorder and cardiovascular complications thereof
#3526Use of immunesuppressant receptor
#3527Cell-permeable peptide inhibitors of the JNK signal transduction pathway
#3528Kit for detecting Cthrc1 in a sample
#3529COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND NEUTROPENIA
#3530Use of Repeat Sequence Protein Polymers in Personal Care Compositions
#3531LIPOSOMES CONTAINING OLIGOPEPTIDE FRAGMENTS OF MYELIN BASIC PROTEIN, A PHARMACEUTICAL COMPOSITION AND A METHOD FOR TREATMENT OF MULTIPLE SCLEROSIS
#3532Prevention And Treatment Of Amyloidogenic Disease
#3533Fertilization prediction and promotion
#3534METHODS OF INHIBITING APOPTOSIS OR INFLAMMATION IN A MAMMAL BY ADMINISTERING AN ISOLATED BCL PROTEIN
#3535Methods of inhibiting photoreceptor apoptosis by eliciting the Faim2 antiapoptotic pathway
#3536NEW FORMULATION FOR INCREASING BIOAVAILABILITY OF NEURTURIN
#3537USE OF HISTONES FOR THE EARLY DIAGNOSIS AND/OR PREVENTIVE THERAPY OF VIRALLY-INFECTED LIVING CELLS AND A BIOCHIP FOR CARRYING OUT SAID DIAGNOSIS
#3538ANTI-INFLAMMATORY FACTORS
#3539Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#3540METHODS FOR TREATMENT OF MICROBIAL DISORDERS
#3541USE OF IL-17E FOR CANCER TREATMENT
#3542COMPOSITION AND METHODS FOR THE PREVENTION AND TREATMENT OF MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND DIABETIC MACULAR EDEMA
#3543Methods for treating diabetic wounds
#3544TREATMENT OF TYPE 2 DIABETES, METABOLIC SYNDROME, MYOCARDIAL INJURY AND NEURODEGENERATION WITH HUMANIN AND ANALOGS THEREOF
#3545Method for weight loss and ketogenic compositions
#3546Method for treating amyloid disease
#3547Immunotherapy against several tumors including gastrointestinal and gastric cancer
#3548STING (STIMULATOR OF INTERFERON GENES), A REGULATOR OF INNATE IMMUNE RESPONSES
#3549BIOMARKER FOR SENSITIVITY TO THERAPY WITH A NOTCH INHIBITOR
#3550Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
#3551Oral care compositions and methods
#3552Lipid formulated dsRNA targeting the PCSK9 gene
#3553Method of treating ischemic injury with follistatin-like 1 polypeptide
#3554METHODS OF TREATING OR PREVENTING PERIODONTITIS AND DISEASES ASSOCIATED WITH PERIODONTITIS
#3555Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis
#3556Natural tissue scaffolds as tissue fillers
#3557Semaphorin 3C (Sema3C) inhibitor therapeutics, methods, and uses
#3558PARENTERAL FORMULATIONS OF PEPTIDES FOR THE TREATMENT OF SYSTEMATIC LUPUS ERYTHEMATOSUS
#3559REGULATION OF BACE DEGRADATION
#3560Methods of diagnosing cancer
#3561Muteins of tear lipocalin and methods for obtaining the same
#3562Methods of treating glucose metabolism disorders
#3563Method for inhibiting cell death during liver failure by administering a caspase recruitment domain
#3564Method for treating brain cancer using a novel tumor suppressor gene and secreted factor
#3565Compositions for improving bone mass
#3566ANTI-VIRAL THERAPY
#3567COMPLEMENT FACTOR H FOR OXIDATIVE STRESS DISEASE CONDITIONS
#3568SIDE POPULATION CELLS IN CARDIAC REPAIR
#3569Therapeutic Agent for infections, and treatment method using the same
#3570Use of Light Sensitive Genes
#3571APOE PEPTIDE DIMERS AND USES THEREOF
#3572DISC-1 pathway activators in the control of neurogenesis
#3573USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#3574Biological Agents Active in Central Nervous System
#3575Method for enzymatically preparing peptides for use in improvement of brain function
#3576Methods for treating atrial or ventricular arrhythmias by administering a G-protein alpha inhibitor
#3577Methods of Inducing Regulated Pancreatic Hormone Production in Non-Pancreatic Islet Tissues
#3578Methods for improving sperm functionality
#3579Amniotic membrane preparations and purified compositions and anti-inflammation methods
#3580Chaperonin 10 variants
#3581Retinoid replacements and opsin agonists and methods for the use thereof
#3582Therapeutics to inhibit MLL-menin interaction for treating leukemia
#3583Methods for treating epithelium trauma of the intestinal mucosa using interleukin-1 receptor antagonist
#3584USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#3585PRG4 treatment for interstitial cystitis
#3586Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins
#3587Methods and compositions for the inhibition of Stat5 in prostate cancer cells
#3588METHODS OF CONTROLLING AXON OR DENDRITE DEVELOPMENT OF NEURONAL CELLS
#3589Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
#3590Methods of Treating Glucose Metabolism Disorders
#3591METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ATHEROSCLEROSIS
#3592Method for treating alzheimer's disease using pharmacological chaperones to increase the activity of gangliosidases
#3593Purified EMD protein composition
#3594Treatment of extracellular matrix to reduce inflammation
#3595USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#3596Method Of Reducing Injury To Mammalian Cells
#3597PEPTIDES FOR PREVENTING OR TREATING A DISEASE OR DISORDER ASSOCIATED WITH CBP OR p300 MISREGULATION, AND METHODS FOR USE AND IDENTIFICATION THEREOF
#3598INHIBITION OF CHOROIDAL NEOVASCULARIZATION
#3599SGEF CONTROLS MACULAR, CORPUS CALLOSUM AND HIPPOCAMPAL FUNCTION AND DEVELOPMENT, LIVER HOMEOSTASIS, FUNCTIONS OF THE IMMUNE SYSTEM, FEVER RESPONSE ATHEROSCLEROSIS AND TUMOROGENIC CELL GROWTH
#3600MOLECULES CAPABLE OF INDUCING CELL DEATH BY TARGETING THE MITOCHONDRIA AND APPLICATIONS THEREOF